AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 166 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $199,000 | -27.9% | 627,549 | -19.8% | 0.00% | – |
| Q2 2022 | $276,000 | -85.6% | 782,675 | -70.7% | 0.00% | -100.0% |
| Q1 2022 | $1,915,000 | -67.3% | 2,666,861 | +2.8% | 0.00% | -50.0% |
| Q4 2021 | $5,862,000 | -2.9% | 2,593,841 | +23.8% | 0.00% | 0.0% |
| Q3 2021 | $6,036,000 | -53.2% | 2,095,763 | -38.5% | 0.00% | -50.0% |
| Q2 2021 | $12,906,000 | +56.8% | 3,405,121 | +40.0% | 0.00% | +33.3% |
| Q1 2021 | $8,231,000 | +68.2% | 2,432,259 | +39.2% | 0.00% | +50.0% |
| Q4 2020 | $4,894,000 | +10.9% | 1,747,304 | -0.6% | 0.00% | 0.0% |
| Q3 2020 | $4,411,000 | -82.9% | 1,757,736 | -7.5% | 0.00% | -81.8% |
| Q2 2020 | $25,794,000 | +84.5% | 1,899,721 | +3.0% | 0.01% | +57.1% |
| Q1 2020 | $13,981,000 | +42.0% | 1,844,423 | +18.4% | 0.01% | +75.0% |
| Q4 2019 | $9,844,000 | +100.0% | 1,557,554 | +24.0% | 0.00% | +100.0% |
| Q3 2019 | $4,923,000 | -3.3% | 1,255,624 | +19.4% | 0.00% | 0.0% |
| Q2 2019 | $5,090,000 | -30.1% | 1,051,736 | +18.3% | 0.00% | -33.3% |
| Q1 2019 | $7,282,000 | +39.7% | 888,981 | -5.7% | 0.00% | +50.0% |
| Q4 2018 | $5,212,000 | +30.1% | 942,599 | +107.8% | 0.00% | 0.0% |
| Q3 2018 | $4,006,000 | +472.3% | 453,627 | +1175.2% | 0.00% | – |
| Q3 2017 | $700,000 | +37.0% | 35,572 | 0.0% | 0.00% | – |
| Q2 2017 | $511,000 | +56.3% | 35,572 | 0.0% | 0.00% | – |
| Q1 2017 | $327,000 | -19.5% | 35,572 | -8.7% | 0.00% | – |
| Q4 2016 | $406,000 | +19.8% | 38,963 | +3.9% | 0.00% | – |
| Q3 2016 | $339,000 | +81.3% | 37,499 | +50.2% | 0.00% | – |
| Q2 2016 | $187,000 | -17.3% | 24,972 | -0.4% | 0.00% | – |
| Q1 2016 | $226,000 | -15.7% | 25,065 | +20.7% | 0.00% | – |
| Q4 2015 | $268,000 | – | 20,765 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 7,031,283 | $95,485,000 | 5.72% |
| GREAT POINT PARTNERS LLC | 3,510,073 | $47,667,000 | 3.81% |
| Logos Global Management LP | 1,200,000 | $16,296,000 | 3.26% |
| DAFNA Capital Management LLC | 762,666 | $10,357,000 | 2.99% |
| Baupost Group | 15,000,000 | $203,700,000 | 2.54% |
| Nantahala Capital Management | 6,101,111 | $82,853,000 | 2.50% |
| Abrams Capital Management | 5,656,462 | $76,815,000 | 2.48% |
| Novo Holdings A/S | 1,987,506 | $26,990,000 | 1.74% |
| Stanley-Laman Group, Ltd. | 316,933 | $4,304,000 | 1.04% |
| Integral Health Asset Management, LLC | 250,000 | $3,395,000 | 1.02% |